Add to ORKGTherapeutic efficacy and safety of paclitaxel/ lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cance
Although nanoparticle-based drug delivery formulations can improve the effectiveness and safety of c...
Although multidrug resistance (MDR) is known to develop through a variety of molecular mechanisms wi...
"Nanoparticle albumin bound paclitaxel (nab-paclitaxel) represents the first nanotechnology-based dr...
The treatment of multi-drug resistant (MDR) cancer is a clinical challenge. Many MDR cells over-expr...
Multidrug resistance is a major problems associated with cancer chemotherapy. Efflux transports is o...
International audienceAs active targeting using nanomedicines establishes itself as a strategy of ch...
Chemotherapy-induced activation of cell survival pathways leads to drug resistance. MicroRNAs (miRNA...
International audienceRecently, active targeting using nanocarriers with biological ligands has emer...
A novel, EGFR-targeted nanomedicine has been developed in the current study. Glutaraldehyde crosslin...
The multidrug resistance (MDR) of tumor cells significantly reduces the efficiency of traditional an...
Resistance to chemotherapy, enhanced proliferation, invasion, angiogenesis, and metastasis (RPIAM) r...
The clinical efficacy of epidermal growth factor receptor (EGFR)-targeted inhibitors is limited due ...
Although advances have been made in reducing mortality rates and improving survival, cancer is still...
The clinical efficacy of epidermal growth factor receptor (EGFR)-targeted inhibitors is limited due ...
Cancer is the leading cause of economic and health burden worldwide. The commonly used approaches fo...
Although nanoparticle-based drug delivery formulations can improve the effectiveness and safety of c...
Although multidrug resistance (MDR) is known to develop through a variety of molecular mechanisms wi...
"Nanoparticle albumin bound paclitaxel (nab-paclitaxel) represents the first nanotechnology-based dr...
The treatment of multi-drug resistant (MDR) cancer is a clinical challenge. Many MDR cells over-expr...
Multidrug resistance is a major problems associated with cancer chemotherapy. Efflux transports is o...
International audienceAs active targeting using nanomedicines establishes itself as a strategy of ch...
Chemotherapy-induced activation of cell survival pathways leads to drug resistance. MicroRNAs (miRNA...
International audienceRecently, active targeting using nanocarriers with biological ligands has emer...
A novel, EGFR-targeted nanomedicine has been developed in the current study. Glutaraldehyde crosslin...
The multidrug resistance (MDR) of tumor cells significantly reduces the efficiency of traditional an...
Resistance to chemotherapy, enhanced proliferation, invasion, angiogenesis, and metastasis (RPIAM) r...
The clinical efficacy of epidermal growth factor receptor (EGFR)-targeted inhibitors is limited due ...
Although advances have been made in reducing mortality rates and improving survival, cancer is still...
The clinical efficacy of epidermal growth factor receptor (EGFR)-targeted inhibitors is limited due ...
Cancer is the leading cause of economic and health burden worldwide. The commonly used approaches fo...
Although nanoparticle-based drug delivery formulations can improve the effectiveness and safety of c...
Although multidrug resistance (MDR) is known to develop through a variety of molecular mechanisms wi...
"Nanoparticle albumin bound paclitaxel (nab-paclitaxel) represents the first nanotechnology-based dr...